China doubles down on promoting yuan as confidence in U.S. dollar takes a beating

China doubles down on promoting yuan as confidence in U.S. dollar takes a beating


Key Points
  • China is introducing ways to bolster yuan’s usage as confidence in the U.S. dollar falters.
  • Three major Chinese exchanges have allowed certain foreign institutional investors to trade more futures and options contracts listed in mainland China.
  • From expanding investment channels to building digital infrastructure, Beijing has been laying the groundwork to accelerate international use of its currency.



Source

Stocks making the biggest moves midday: Novo Nordisk, Inspire Medical, Tesla, Tegna, Oscar Health and more
Finance

Stocks making the biggest moves midday: Novo Nordisk, Inspire Medical, Tesla, Tegna, Oscar Health and more

Check out the companies making the biggest moves midday: Novo Nordisk — The Danish pharmaceutical company’s trial for Alzheimer’s disease failed to meet its main goal of slowing the disease’s progression. Shares tumbled nearly 6%. Inspire Medical Systems — The maker of an obstructive sleep apnea treatment will benefit from Friday’s decision by the Centers […]

Read More
Michael Burry launches newsletter to lay out his AI bubble views after deregistering hedge fund
Finance

Michael Burry launches newsletter to lay out his AI bubble views after deregistering hedge fund

Michael Burry attends the New York premiere of “The Big Short” at the Ziegfeld Theater in New York City on Nov. 23, 2015. Jim Spellman | WireImage | Getty Images Michael Burry, the investor who shot to fame for calling the housing crash before 2008, has launched a Substack newsletter after deregistering his hedge fund, […]

Read More
Stocks making the biggest moves premarket: Novo Nordisk, Tesla, Alphabet, Oscar Health & more
Finance

Stocks making the biggest moves premarket: Novo Nordisk, Tesla, Alphabet, Oscar Health & more

Check out the companies making the biggest moves in premarket trading: Novo Nordisk — Shares tumbled 10% after the Danish pharmaceutical company’s trial for Alzheimer’s disease failed to meet its main goal of slowing the disease’s progression. Tesla — CEO Elon Musk said on X that the company is close to finalizing its latest artificial-intelligence […]

Read More